Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size (NOMI)
This study is currently recruiting participants.
Verified January 2013 by Universitaire Ziekenhuizen Leuven
Study NCT01398384   Information provided by Universitaire Ziekenhuizen Leuven

First Received on July 18, 2011.   Last Updated on January 23, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Myocardial Infarction
Additional conditions recognized in this trial
Infarction
Myocardial Infarction
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Ischemia
Myocardial Ischemia
Necrosis
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Nitric Oxide
MI size at 48-72 hours
More general drug interventions related to this trial
Anti-Asthmatic Agents
Antioxidants
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Endothelium-Dependent Relaxing Factors
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Universitaire Ziekenhuizen Leuven


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services